GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » EBIT

The Chemours Co (The Chemours Co) EBIT : $-110 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is The Chemours Co EBIT?

The Chemours Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $-18 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $-110 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. The Chemours Co's annualized ROC % for the quarter that ended in Dec. 2023 was -0.20%. The Chemours Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1.89%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. The Chemours Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1.54%.


The Chemours Co EBIT Historical Data

The historical data trend for The Chemours Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Chemours Co EBIT Chart

The Chemours Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.00 389.00 861.00 904.00 -110.00

The Chemours Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.00 215.00 -385.00 78.00 -18.00

Competitive Comparison of The Chemours Co's EBIT

For the Specialty Chemicals subindustry, The Chemours Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Chemours Co's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, The Chemours Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The Chemours Co's EV-to-EBIT falls into.



The Chemours Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-110 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Chemours Co  (NYSE:CC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The Chemours Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-32 * ( 1 - 67.9% )/( (5226 + 4904)/ 2 )
=-10.272/5065
=-0.20 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

The Chemours Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-72/( ( (3377 + max(621, 0)) + (3476 + max(151, 0)) )/ 2 )
=-72/( ( 3998 + 3627 )/ 2 )
=-72/3812.5
=-1.89 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(753 + 1314 + 671) - (1870 + 0 + 247)
=621

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(509 + 1352 + 670) - (2144 + 0 + 236)
=151

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

The Chemours Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-110/7163.428
=-1.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Chemours Co EBIT Related Terms

Thank you for viewing the detailed overview of The Chemours Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


The Chemours Co (The Chemours Co) Business Description

Traded in Other Exchanges
Address
1007 Market Street, Wilmington, DE, USA, 19801
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, it derives a majority of its revenue from North America.
Executives
Ron Christopher Charles officer: Senior Vice President, People C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sandra Phillips Rogers director 1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Erin N Kane director 300 KIMBALL DRIVE, SUITE 101, PARSIPPANY NJ 07054
Joseph T. Martinko officer: President, Thermal & Specializ C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Mark Newman officer: Senior Vice President and CFO 1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Alvenia Scarborough officer: SVP Corp Communications & CBO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Matthew S Abbott officer: SVP, Chief Enterprise Transfor C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Guillaume Pepy director C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sean D Keohane director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Calderon Gerardo Familiar officer: Pres Advanced Performance Mat C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Alisha Bellezza officer: President, Thermal Spec Solns C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Camela Wisel officer: VP, CAO & Controller C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sameer Ralhan officer: SVP, CFO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19899
Jonathan Lock officer: SVP, Chief Development Officer C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Susan M. Kelliher officer: SVP, People and Health Service ALBEMARLE CORPORATION, 451 FLORIDA STREET, BATON ROUGE LA 70801